SNOA Earnings
Latest Revenue6.4M
Latest Net Income-330000
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q1 2027 | -$0.09 | 6.4M | -330000 | +59.6% | +88.2% |
| Q4 2026 | -$0.33 | 5.6M | -581000 | +48.1% | +31.2% |
| Q3 2026 | -$0.48 | 4.3M | -819000 | +22.0% | +23.8% |
| Q2 2026 | -$0.32 | 5.6M | -534000 | +56.6% | +45.8% |
| Q1 2026 | -$0.76 | 4.0M | -1241000 | +18.4% | +43.3% |
| Q4 2025 | -$0.48 | 3.8M | -776000 | +9.2% | +31.4% |
| Q3 2025 | -$0.63 | 3.6M | -928000 | +13.6% | +60.4% |
| Q2 2025 | -$0.59 | 3.6M | -610000 | +31.1% | +89.7% |
| Q1 2025 | -$1.34 | 3.4M | -1143000 | — | — |
| Q4 2024 | -$0.70 | 3.4M | -1067000 | — | — |
| Q3 2024 | -$1.59 | 3.1M | -866000 | — | — |
| Q2 2024 | -$5.75 | 2.7M | -1484000 | — | — |
Sonoma Pharmaceuticals (SNOA) — Earnings